logo
Questions? +1 (202) 335-3939 Login
Set Up FREE Account Submit Release
Trusted News Since 1995
A service for investment professionals · Wednesday, November 27, 2024 · 764,403,213 Articles · 3+ Million Readers
Home  •••  Newswires by Industry  •  Countries  •  U.S. States  •  World Media Directory
Investing News  •••  Topics  •  Countries  •  U.S. States

Pfizer Shares News Monitoring

  • Published on 12:29 GMT

    Billionaires Are Buying Up Beaten-Down Pfizer Stock. Should You Follow Their Lead?

    Nobody can predict the future, but it's not hard to imagine increasing pharmaceutical sales. In 2022, prescription drug spending in the U.S. climbed more than 8% to reach $406 billion. It's a lot but still less than one-third of the amount soaked …

    Source: Yahoo Finance - Label Pending
  • Published on Nov 25, 2024

    Pfizer And Schlumberger Are January Bounce Candidates

    The "January Bounce" is a Wall Street tradition. Stocks hurt in a given year often bounce back in ... [+] January, as tax-motivated selling abates.getty Stocks that struggle during the first ten months of the year often fall further during …

    Source: Forbes - Neutral
  • Published on Nov 25, 2024

    FDA Nod for BridgeBio Brings New Competition to Blockbuster Pfizer Cardio Drug

    A BridgeBio Pharma drug developed for an increasingly prevalent cardiovascular condition has won FDA approval, marking a comeback for a company and a molecule with a turbulent history. But BridgeBio’s challenges aren’t over. The biotech’s new product must …

    Source: MedCity News - Neutral
  • Published on Nov 22, 2024

    Pfizer Stock Drops 10% In November On News Of Kennedy's HHS Nomination

    Pfizer Inc PFE shares are trading lower by 10% to $25.13 in November and are near decade-lows after President-elect Donald Trump last week announced his intention to nominate Robert F. Kennedy Jr. to lead the Department of Health and Human Services (HHS). …

    Source: Benzinga - Neutral
  • Published on 14:13 GMT

    The Biggest Pharma Share Moves of the Year So Far

    The most dramatic positive share moves of the year for the top pharma companies tell compelling stories of blockbuster drug sales, exciting drug approvals and competitor misses. And on the flip side, companies with noticeable dips in share prices faced …

    Source: BioSpace - Label Pending
  • Published on 16:21 GMT

    Kronos, Idorsia plan layoffs; PTC shelves ALS drug

    Today, a brief rundown of news involving Kronos Bio, Idorsia and PTC Therapeutics, as well as updates from Alnylam Pharmaceuticals and Soleno Therapeutics that you may have missed. Kronos Bio will lay off 83% of its workforce by year’s end and its CEO, …

    Source: BioPharma Dive - Label Pending
  • Published on Nov 26, 2024

    Current, Future and Former Dividend Aristocrats Yielding Over 4% to Buy in November 2024

    Investing Panchenko Vladimir / Shutterstock.com Maintaining dividend aristocrat status isn’t easy, as it requires companies to pay out dividends consistently (and raise them each year) for 25 consecutive years, while maintaining a $3 billion market …

    Source: 24/7 Wall St. - Neutral
  • Published on Nov 26, 2024

    Incorporate A Company In United States In 2025

    The United States of America (USA), often referred to as the “land of opportunities,” is a federal republic consisting of 50 states. Bordered by Canada to the north and Mexico to the south, it spans from the Atlantic Ocean in the east to the Pacific Ocean …

    Source: Inventiva - Neutral
  • Published on Nov 26, 2024

    2 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income

    Investors looking for a way to pump up their passive income streams want to turn their attention toward the pharmaceutical industry. From the end of 2022 through Nov. 22, the benchmark S&P 500 index rose by a stunning 55.5%, but many of its drug- …

    Source: Yahoo Finance - Label Pending
  • Published on Nov 25, 2024

    Biotechs test IPO market despite concerns over Kennedy’s health role

    Unlock the White House Watch newsletter for free Your guide to what the 2024 US election means for Washington and the world Two drug developers are pressing ahead with public listings in the coming months despite fears that Robert F Kennedy Jr’s nomination …

    Source: The Financial Times - Neutral
  • Published on Nov 25, 2024

    Dr Boreham’s Crucible: The rise and rise of LTR Pharma

    When we were kids eyeing an unobtainable treat or the not-so-imminent arrival of Santa, Mum used to tell us to be patient. Patience, indeed, is a virtue and an admirably quality to exhibit throughout one’s adult life. But there are circumstances when even …

    Source: Stockhead - Neutral
  • Published on Nov 25, 2024

    Finding Winners In Biotech, Probably The Riskiest Sector

    Bill Oxford Listen here or on the go via Apple Podcasts and Spotify Jonathan Faison shares his approach to investing in biotech, the 'riskiest' sector (1:35). Recent lows and seeing through the volatility (4:10). Sector winners (9:20). Do sector …

    Source: Seeking Alpha - Label Pending
  • Published on Nov 25, 2024

    One Sector Has Underperformed Massively: These 4 Blue-Chip Dividend Giants Are Huge 2025 Plays

    Investing Ridofranz / iStock via Getty Images This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Key Points Donald Trump’s victory is positive for the stock …

    Source: 24/7 Wall St. - Neutral
  • Published on Nov 25, 2024

    Q3 Earnings Season: Outlook Looks Murky for Traders

    Editor’s note: Any and all references to time frames longer than one trading day are for purposes of market context only, and not recommendations of any holding time frame. Daily rebalancing ETFs are not meant to be held unmonitored for long periods. If …

    Source: ETF Trends - Neutral
  • Published on Nov 25, 2024

    TotalEnergies halts Adani investments; GQG bets on Indian govt backing

    Mumbai and Bengaluru: France’s TotalEnergies SE, which owns just under a fifth of Adani Green Energy Ltd, has decided not to invest more capital in Adani group companies following the indictment of the Indian conglomerate’s top executives in a $250-million …

    Source: Mint - Neutral
  • Published on Nov 25, 2024

    SEBI Slaps Rs 25L Fine, 1-Year Market Ban on 2 Individuals For Insider Trading in Jagsonpal Pharma

    Individually, the regulator slapped a fine of Rs 15 lakh on Maneesh Kumar Jain and Rs 10 lakh on S V Subha Rao (former Chief Finance Officer of Jagsonpal Pharmaceuticals Ltd), Sebi said in an order passed on Friday. Apart from these, the regulator has also …

    Source: Medical Dialogues - Uncategorized
  • Published on Nov 25, 2024

    Evotec on the brink of acquisition: At what cost for the biotech industry?

    It’s fair to say Evotec has been part of the European biotech landscape for quite some time. Indeed, it was founded in 1993 in Hamburg, Germany, and stands out as a rare breed: part service provider, part innovator. As a contract research organization (CRO …

    Source: Labiotech - Neutral
  • Published on Nov 25, 2024

    BridgeBio: Next Chapter Begins After Attruby Approval

    BridgeBio announced the FDA approval of Attruby (acoramidis) for the treatment of patients with ATTR-CM. The label looks clean and it includes all the relevant clinical data. Attruby's approval also triggers a $500 million milestone payment to …

    Source: Seeking Alpha - Label Pending
  • Published on Nov 24, 2024

    5 Moonshot Stocks to Buy for 2025 

    Tom Yeung here with this week’s Sunday Digest.  Many of you will know that I am a relatively conservative investor. I pay close attention to a company’s long-term profitability, and to me, cash flow is king. There’s nothing wrong with earning 10% dividends …

    Source: InvestorPlace - Neutral

05 days 05:24:37

Send 2 Free
Press Releases
Use them anytime within 12 months

Featured Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.
Load more investing news or search news using your own keywords. There are 764,403,213 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Investing News by Country >
Investing News by U.S. State >
Investing News Topics >
Online News Publications >
World News Report >

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter >
Create RSS Feed >
NewsPlugin for WordPress >

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire >
Events >

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 11/19/2024

World Media Directory >

Banking, Finance & Investment Industry Press Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.

Banking, Finance & Investment Events

See All

No event was found.

Become a Member - Join Today!
Join thousands of professionals. Stay current. Stay competitive.
  • Track news from thousands of sources
  • Submit news sources for inclusion in our news tracking algorithm
  • Build your own customized email newsletters
  • Use of our RSS Feeds
  • Includes a complimentary EIN Presswire account plus 1-free release
  • Uncluttered & advertising free news pages

Global Investing Today by EIN Newsdesk & EIN Presswire (a press release distribution service)

Follow us on Facebook & Twitter and connect with us on LinkedIn

Newsmatics Inc., 1025 Connecticut Avenue NW, Suite 1000, Washington, DC 20036 · Contact · About

© 1995-2024 Newsmatics Inc., a publisher of EIN News · All Rights Reserved · Privacy Policy · User Agreement